Suramin in Treating Patients With Refractory or Relapsed Multiple Myeloma or Castleman's Disease

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of suramin in treating patients who have refractory or relapsed multiple myeloma or Castleman's disease.

Timeline

Start

1995-05

Primary completion

—

Completion

2004-02

Drugs

Indications